U.S. Energy Boom Ke...
Health Care: Drugs
Quidel Corporation (QDEL: NASDAQ)
$22.62 0.52 | 2.35%
05/24/13 - 04:00 PM ET
Company Profile
| Price and Volume | |
|---|---|
| Recent Price | 22.10 |
| 52 Week High | 24.95 |
| 52 Week Low | 14.92 |
| Avg. Daily Vol. (Mil) | 0.25 |
| Beta (3 year) | 0.52 |
| Share Related Items | |
| Mkt Cap (Mil) | 745.46 |
| Shares Out (Mil) | 33.73 |
| Float (Mil) | 24.44 |
| Dividend Information | |
| Yield % | 0.00 |
| Annual Dividend | 0.00 |
| Payout Ratio | 0.00 |
| Financial Strength | |
| Quick Ratio | 2.60 |
| Current Ratio | 4.00 |
| LT Debt/ Equity | 0.03 |
| Total Debt / Equity | 0.03 |
| Valuation Ratios | |
| Price Earnings | 43.30 |
| Price/Sales | 4.15 |
| Price/Book | 3.41 |
| Price/Cash Flow | 17.70 |
| Per Share Data | |
| Earnings | 0.51 |
| Sales | 5.33 |
| Book Value | 6.48 |
| Cash Flow | 1.25 |
| Business Summary | |
|---|---|
| Quidel Corporation develops, manufactures and markets diagnostic testing solutions for applications mainly in infectious diseases and reproductive and women's health. | |
| General Information | |
| 10165 McKellar Court
San Diego, CA 92121 |
|
| www.quidel.com | |
| Industry : Drugs | |
| Sector: Health Care | |
| Employees: 514 | |
| CEO: Douglas C. Bryant | |
| Short Interest | |
| Current Month (Mil) | 4.23 |
| Previous Month (Mil) | 3.95 |
| Short Interest Ratio (Days) | 18.70 |
| Management Effectiveness | |
| Return on Equity | 7.90 |
| Return on Assets | 6.70 |
| Return on Investments | 7.70 |
| Profitability | |
| Gross Margin | 73.20 |
| EBIT Margin | 14.20 |
| Profit Margin | 9.60 |
Portfolios with QDEL
- Portfolio NameUser Type
- ContributorStocks Rising On Unusual Vo...
- ContributorEarnings Short Squeeze Play...
- ContributorStocks With Big Insider Buy...
- ContributorEarnings Short Squeeze Play...
- ContributorBreakout Stocks Of The Week...
- Contributor2011 Santa Claus Rally Stra...
- UserMatt Picks
- ContributorBarron's Insider Purchases ...
- UserPART 7 JPMorgan 28th Annual...
- ContributorBarron's Insider Purchases ...
Latest QDEL Headlines from TheStreet
- Quidel Corporation Stock Upgraded (QDEL) 02.14.13 | 04:02 am
- Quidel's CEO Presents At Canaccord Genuity 32nd Annual Growth Conference (Transcript) 08.14.12 | 04:08 pm
- Quidel Corporation Stock Downgraded (QDEL) 07.30.12 | 05:07 am
- Quidel's CEO Discusses Q2 2012 Results - Earnings Call Transcript 07.26.12 | 01:07 am
- Quidel's CEO Presents At Goldman Sachs Healthcare Conference (Transcript) 06.06.12 | 08:06 pm
- Quidel's CEO Discusses Q1 2012 Results - Earnings Call Transcript 04.25.12 | 11:04 pm
- Quidel Stock Hits New 52-Week High (QDEL) 04.03.12 | 11:04 am
- 5 Stocks Insiders Love Right Now 03.29.12 | 12:03 pm
- Quidel Corporation Stock Upgraded (QDEL) 03.29.12 | 05:03 am
- Insiders Trading SPB, EXPR, QDEL 03.22.12 | 09:03 am
Press Releases for QDEL
- Quidel And Life Technologies Receive FDA Clearance For Clostridium Difficile Assay And QuantStudioâ¿¢ Dx And 7500 Fast Dx Real-Time PCR Instruments - PR Newswire 03.18.13 | 08:03 am
- Quidel Reports Fourth Quarter And Full Year 2010 Results - Business Wire 02.24.11 | 04:02 pm
- Quidel To Present At JP Morgan 29th Annual Healthcare Conference - Business Wire 01.07.11 | 01:01 pm
- Quidel Announces Pricing Of Common Shares Offering - Business Wire 01.06.11 | 09:01 am
- Quidel Announces Proposed Common Shares Offering - Business Wire 01.05.11 | 04:01 pm
- Quidel Reports Third Quarter 2010 Results - Business Wire 10.27.10 | 04:10 pm
- Quidel To Hold Third Quarter 2010 Results Conference Call On October 27, 2010 - Business Wire 10.13.10 | 07:10 pm
- Quidel Announces FDA Clearance Of Its QuickVue® RSV 10 Immunoassay Diagnostic Test - Business Wire 09.29.10 | 07:09 am
- Quidel Announces FDA Clearance Of Its RapidVue® HCG Pregnancy Lateral Flow Diagnostic Test - Business Wire 08.31.10 | 04:08 pm
- Quidel To Present At Canaccord Genuity 30th Annual Growth Conference - Business Wire 08.04.10 | 06:08 pm
Partner Headlines for QDEL
- UPDATE: Piper Jaffray Initiates Quidel at Overweight on Long-Term Outlook - Benzinga 10.04.12 | 01:10 pm
- FDA Nod for Quidel's hMPV Test - Analyst Blog - Zacks 12.27.11 | 06:12 pm
- Quidel Receives CE Mark for Its Sofia Strep A Fluorescent Immunoassay Test - Benzinga 12.01.11 | 01:12 pm
- Quidel Receives 510(k) Clearance of Its Sofia Fluorescent - Benzinga 10.26.11 | 01:10 pm
- Wedbush Lowers Q3 Estimate on Quidel - Benzinga 10.26.11 | 09:10 am
- 8 Oversold, Shorted Stocks Reporting Earnings Next Week, Being Bought By Smart Money - Seeking Alpha 07.28.11 | 09:07 am
- Insider Buying: 8 Recent CEO Buys of More Than $100,000 - Seeking Alpha 06.10.11 | 09:06 am
- UPDATE 1-Quidel sees Q4 revenue below Street view; shrs down - Reuters 01.05.11 | 05:01 pm
- Torpedo Watch List: Large and Small Cap Stocks to Avoid - Seeking Alpha 11.17.10 | 06:11 am
- 9 Stocks That Should Be on Every Contrarian's Radar - Seeking Alpha 09.10.10 | 05:09 pm
